Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Xiu Liu

2PUBLICATIONS

14CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jun 03, 2026

Glucose restriction reprograms lipid metabolism and enhances immunotherapy through ZNRF3-Wnt-SCD signaling axis.

|Jul 21, 2022

Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort study.

Xiu Liu, Kai Ou, Xiaoting Ma

Pageof 1

Frequent Collaborators

1 joint publications

Kai Ou

1 joint publications

Xiaoting Ma

1 joint publications

Lin Yang

1 joint publications

Yarui Ma

1 joint publications

Qi Zhang

1 joint publications

Zhewen Wei

1 joint publications

Zhendiao Zhou

1 joint publications

Xue Wang

1 joint publications

Chungui Xu

1 joint publications

Shitong Min

Frequent Collaborators

1 joint publications

Kai Ou

1 joint publications

Xiaoting Ma

1 joint publications

Lin Yang

1 joint publications

Yarui Ma